Tools chosen: polymarket_direct polymarket_related kalshi_related claude_news claude_news earnings_data gdelt_news wikipedia code_execution

Sub-questions (Fermi decomposition)

Planner reasoning

This is a multi-outcome-style corporate M&A race: WBD's board accepted a Netflix deal for the studios/streaming assets while Paramount Skydance mounted a hostile tender offer, so the market price for 'Paramount closes' depends on tender-offer success, shareholder vote outcomes, financing, and antitrust/regulatory timelines through mid-2027. The Polymarket price is the primary anchor, supplemented by news on the bidding contest and cross-venue checks.

# Current state Paramount Skydance's $31/share all-cash tender offer for WBD prevailed over Netflix's earlier board-backed deal; WBD's board flipped to Paramount and signed a definitive merger agreement (Feb 27, 2026). Federal (DOJ, June 12, 2026) and EU antitrust clearance are secured, but 12 states + WGA sued (July 13, 2026) to block the deal, a federal judge found the states' theory "plausible," and Paramount stipulated not to close until 5 days after a trial or June 1, 2027 — with trial set for March 2–15, 2027 and post-trial briefing due April 5, 2027, leaving a tight window before this market's June 30, 2027 deadline. # Timeline of key events - 2025-12-05: WBD board signs merger agreement with Netflix, $27.75/share cash-and-stock (~$82.7B EV). Confirmed (Netflix IR). - ~2026-01: Paramount launches unsolicited all-cash tender offer at $30/share for all of WBD. Confirmed (Paramount IR). - 2026-02 (raised): Paramount raises offer to $31/share. Confirmed (Paramount IR). - 2026-02-26: WBD board deems Paramount's $31/share proposal a "Company Superior Proposal" over Netflix deal. Confirmed (SEC filing). - 2026-02-27: Definitive merger agreement signed between WBD, Paramount Skydance, and Prince Sub Inc.; Ellison family guarantee, RedBird equity backing; $7B regulatory termination fee; Paramount assumes $2.8B Netflix breakup fee; ticking fee $0.25/quarter after Sept 30, 2026. Confirmed (SEC). - 2026-06-12: DOJ approves the merger federally. Confirmed (Wikipedia, CNN). - 2026-07-13: 12 states (led by CA) + WGA sue to block merger on antitrust grounds. Confirmed (CNN, NPR, WaPo). - 2026-07-20/24: Federal judge temporarily pauses deal; Paramount stipulates not to close until 5 days post-trial or June 1, 2027. Confirmed (CNBC, CNN, Yahoo). - 2026-08-04/05: Judge sets antitrust trial for March 2–15, 2027 (denying Paramount's request for fall 2026 trial); post-trial briefing due April 5, 2027. Confirmed (Wikipedia, thewrap, screendaily). - 2026-08-06: UK moves Paramount-WBD deal to in-depth competition review. Reported (Hollywood Reporter). - 2026-08-14: WBD shares rally ~7.5% in 8 sessions, narrowing spread to Paramount's $31 offer to ~$3, tightest since March. Reported (Bloomberg). - 2026-08-15: Reports of Mexico regulatory approval as possibly the final outstanding hurdle. Reported (comingsoon.net). # Event Will Paramount close its Warner Bros. Discovery acquisition (studios + streaming) by June 30, 2027, 11:59 PM ET? # Outcomes to forecast - Yes (Paramount closes acquisition by 6/30/2027) - No (deal does not close by 6/30/2027 — includes blocked, delayed, or Netflix/other acquirer scenarios) # Kalshi market anchor No Kalshi-direct price returned for this ticker (kalshi_direct tool did not surface data; kalshi_related returned only unrelated Greenland/territory markets). Using the polymarket_direct feed for this exact ticker as the best available consensus proxy: **current YES price 73.5%**, flat over 7d/30d, 90-day range 62–86.5%, total volume ~$525K. Treat as anchor in place of missing Kalshi price. # Sub-question answers 1. **Paramount tender status** — Superseded; Paramount's tender evolved into a signed definitive merger agreement (Feb 27, 2026) after WBD board declared it a "Superior Proposal," so the tender-condition question is moot. [SEC filings] 2. **Netflix agreement status** — Terminated in favor of Paramount; WBD paid/Paramount assumed a $2.8B Netflix breakup fee. No shareholder vote pending on Netflix deal. [SEC, Netflix IR] 3. **Share price vs. offer** — WBD trading near $28 vs. $31 Paramount cash offer as of mid-Aug 2026 (~$3 spread, narrowest since March), signaling rising market confidence in closing. [Bloomberg 8/14/26]. (Code-execution model used stale/hypothetical Netflix-era inputs — unreliable, disregard.) 4. **Regulatory/political signals** — DOJ (6/12/26) and EU (with divestiture conditions) cleared; UK opened in-depth review (8/6/26); Mexico approval reportedly pending/near (8/15/26); Trump admin previously signaled preference against Netflix, favorable to Paramount-Ellison ties (Delrahim leads Paramount defense). [Wikipedia, CNBC, Fortune, Hollywood Reporter] 5. **Financing** — Ellison family guarantee + RedBird Capital equity subscription agreements back the deal; deemed credible per signed merger agreement terms. [SEC filing] 6. **Litigation** — Delaware court denied Paramount's expedition motion pre-flip (moot now); active federal antitrust case: 12 states + WGA suit, judge found states' theory plausible, trial March 2–15, 2027, briefing due April 5, 2027; separate shareholder suit on editorial-independence grounds (July 2026). [CNN, NPR, TheHill, Yahoo] 7. **Other markets** — Polymarket sibling/related searches returned no separate Netflix/Comcast/"none" outcome markets found; Kalshi-related search found no Paramount/WBD matches (only irrelevant Greenland/territory markets). # Key facts (high-confidence, factual) 1. [SEC/Wikipedia] Merger agreement signed 2/27/2026: $31/share all-cash, $7B regulatory termination fee, $0.25/quarter ticking fee after 9/30/26. 2. [Wikipedia] DOJ approved 6/12/2026; deal delayed to as late as 6/1/2027 per stipulation (7/24/26). 3. [Wikipedia/thewrap] Trial set March 2–15, 2027; outside date March 4, 2027 with automatic extension to June 4, 2027 if only regulatory conditions remain. 4. [CNN/NPR] 12 states + WGA suing since 7/13/2026; federal judge found states' antitrust theory plausible. 5. [Bloomberg 8/14/26] Spread narrowed to ~$3 (~90% of offer value), signaling market optimism. # Cross-market signals - Kalshi related: only irrelevant Greenland/territory-acquisition markets found; no direct WBD/Paramount comparator. - Polymarket (this ticker): 73.5% YES, stable, moderate volume ($525K). - Sportsbook implied: N/A (not applicable to M&A). # Analyst opinions and speculation - Fortune (8/3/26): deal "slipping toward a costly legal and financial cliff" given litigation costs/ticking fees. - Motley Fool (7/30/26): framed as a bet on the 12 state AGs' litigation outcome, not media fundamentals. - Bloomberg (8/14/26): traders growing more confident deal closes despite litigation. # Directional lean per outcome - **Yes**: Federal/EU clearance secured, financing committed, narrowing arb spread, Polymarket at 73.5%, UK/Mexico approvals reportedly progressing. - **No**: March 2027 trial timing is extremely tight against June 30, 2027 deadline (only ~3 months buffer including appeals/closing mechanics); judge found states' antitrust theory plausible; multiple pending suits (WGA, shareholder/editorial); outside date extension mechanics add uncertainty. # Gaps / unknowns - No live Kalshi YES price obtained; WBD/PSKY real-time quotes unavailable (FMP 403 errors). - Outcome of March 2027 trial and any appeal timeline unknown. - Status of UK/Mexico/other remaining international approvals unresolved as of last data (mid-Aug 2026). # Calibration anchors - Polymarket YES price (proxy anchor): 73.5%, range 62–86.5% over 90 days. - Precedent: large contested M&A with active state AG litigation and tight closing windows historically show elevated break risk even after federal antitrust clearance (e.g., prior big-media mergers facing state suits).

1. Both forecasts land on an identical 70/30 split despite differing confidence levels (0.55 vs 0.62), suggesting anchoring to the Polymarket price rather than independent modeling of the timeline mechanics — this convergence should be scrutinized as potential herding rather than confirmation. 2. Neither forecast models the sequential critical-path risk in enough detail: trial ends 3/15/27, briefing due 4/5/27, then a ruling must issue, survive any stay/injunction request, and closing must occur by 6/30/27 (or the extended 6/4/27 outside date) — leaving essentially zero slack for appeal or even a modestly delayed ruling, which is a stronger "No" signal than either rationale conveys. 3. Only Forecast 1 mentions the outside-date extension to June 4, 2027; Forecast 2 omits it entirely, creating an inconsistency in the evidentiary basis between the two forecasts on a key mechanical detail that materially affects timing risk. 4. Neither forecast addresses what happens if Paramount prevails at trial but the losing states seek an emergency injunction pending appeal — a plausible scenario for state AGs in a "plausible" antitrust case that could push the actual close past 6/30/27 even in a "Yes" merits outcome. 5. The UK Phase 2 "in-depth" competition review (opened 8/6/26) is noted as unresolved by both, but neither incorporates the reference-class fact that UK Phase 2 reviews often run 24-38 weeks, which alone could threaten the June 2027 deadline independent of the US litigation — this risk is underweighted in both rationales. 6. Neither rationale accounts for the fact that Polymarket's resolution criteria/timeline may not exactly mirror this question's fixed June 30, 2027 cutoff, so treating 73.5% as a clean anchor for this specific deadline (rather than a looser "does it ever close" market) could overstate the true probability for this exact resolution date.

65% (58% confidence)

Yes: 65% No: 35%

Fundamentals lean strongly toward eventual closing: a signed definitive agreement, DOJ and EU clearance, committed Ellison/RedBird financing, a $7B regulatory reverse-termination fee, and a narrowed ~$3 arb spread all indicate high market confidence — and state-AG-only antitrust challenges after federal clearance have historically failed (e.g., T-Mobile/Sprint). However, the critique's core point stands: the 73.5% Polymarket proxy is likely closer to a 'does it ever close' probability, while this question requires consummation by a hard June 30, 2027 date with essentially no slack — trial ends 3/15/27, briefing closes 4/5/27, a ruling must then issue, any injunction-pending-appeal request must be resolved, remaining UK Phase 2 and Mexico approvals must land, and the deal's own extended outside date (June 4, 2027) precedes the market cutoff. Decomposing: ~75-80% Paramount prevails or settles favorably, times ~82-85% that a win converts into an actual close inside the window, yields roughly 0.65. I therefore shade modestly below both forecasters' 0.70 and further below the anchor to reflect the sequential critical-path timing risk both rationales underweighted.

Total pipeline time: 290.5s